Designer drugs current perspective late effort appetite pharmacological substances abuse need profit unscrupulous chemists clandestine laboratories market new drugs street sale common industrial chemicals controlled substances fentanyl meperidine mescaline amphetamine phencyclidine derivatives parent able guidelines Federal Controlled Substances Act due new unique chemical structures users drugs article comprehensive review Designer Drugs historical data pharmacokinetics treatment abuse trends recent additions social pharmacopoeia 